Structural Formula (Cymbalta 01)
Cymbalta
Product Images NDC 68151-4679
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cymbalta (NDC 68151-4679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 3 (Cymbalta 02)
Figure 4 (Cymbalta 03)
Figure 5 (Cymbalta 13)
Figure 6 (Cymbalta 14)
Figure 7 (Cymbalta 15)
This is a graph that shows the percentage of patients who have improved after taking either a placebo or CYM60/120 mg once daily. The X-axis shows the percentage improvement in pain from baseline, while the Y-axis shows the percentage of patients who have improved. The graph indicates that significantly more patients improve after taking CYM60/120 mg once daily than after taking a placebo.*
Figure 8 (Cymbalta 16)
This is a graph depicting the percentage of patients improved in pain from baseline. It shows two different lines, one for placebo and the other for CYMB0 mg once daily. The graph ranges from 0% to 100% and shows the percentage of patients improved in increments of 10%.*
Figure 9 (Cymbalta 17)
This text describes a chart showing the percentage of patients who have improved after taking a placebo or CYM60/120mg once daily. The chart also displays the percent improvement in pain from baseline (BOCF).*
Figure 1 (Cymbalta 18)
This appears to be a graph showing the proportion of patients with relapse over time from randomization to relapse (in days). The graph includes two treatments, "Placebe" and "CYMBALTA". The x-axis shows time in days from 0 to 250, and the y-axis shows the proportion of patients with relapse, ranging from 0 to 1.0. The graph also includes tick marks at 50, 100, 150, and 200 on the x-axis.*
Figure 2 (Cymbalta 19)
Label Image (Lbl681514679)
This is a prescription drug label for Cymbalta (duloxetine) by the manufacturer Lilly. The medication is in the form of a 30 mg delayed-release capsule with lot number C116094A and expiration date 07/14. The other characters may be internal codes and not relevant for general use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
